Small interfering ribonucleic acids (siRNAs) are originally recognized as an intermediate of
the RNA interference (RNAi) pathway. They can inhibit or silence various cellular pathways …

Over the past two decades, small interfering RNA (siRNA) has gained widespread popularity
as an efficient tool for cancer therapy. Unfortunately, due to its inherent instability, the …

RNA interference (RNAi) has increased the possibility of restoring RNA drug targets for
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …

Small interfering RNA (siRNA) has been identified as a useful therapeutic resource in
cancer therapy. Molecular manipulation with siRNA has been reported to have high …

Small interfering RNA (siRNA) delivery by nanocarriers has been identified as a promising
strategy in the study and treatment of cancer. Short nucleotide sequences are synthesized …

RNA interference (RNAi) is a naturally occurring regulatory process that controls
posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi …

Nanomedicine is a growing research field dealing with the creation and manipulation of
materials at a nanometer scale for the better treatment, diagnosis and imaging of diseases …

Purpose To explore current developments in short interfering RNA (siRNA) delivery systems
in nanooncology, in particular nanoparticles that encapsulate siRNA for targeted treatment …

During recent decades there have been remarkable advances and profound changes in
cancer therapy. Many therapeutic strategies learned at the bench, including monoclonal …

Ribonucleic acid interference therapy is a promising cancer treatment, which uses small
interfering RNAs (siRNAs) to target and degrade messenger RNAs. Due to endogenous …